About Stig Hansen, Ph.D.
Form D filings for Carmot Therapeutics in 2023 list Stig Hansen, Ph.D. as director.
Stig Hansen, Ph.D. first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Stig Hansen, Ph.D. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Stig Hansen, Ph.D. works with at each company, as listed on that company's latest Form D.
Carmot Therapeutics Inc. · Form D, Jun 6, 2023
AD
Anne Phillips, M.D.
Director
TK
Tim Kutzkey
Director
PS
Peter Svennilson
Director
AT
Aetna Wun Trombley
Director
TG
Timothy Garnett
Director
HT
Heather Turner
Chief Executive Officer and director